Quantum Pharmaceuticals, the owner of this blog, is proud to release version 2.0 of its innovativ HERG protein binding prediction software.
QUANTUM hERG (q-hERG) screening assays is a unique and innovative computational approach, which allows you to predict from a molecule structures of compounds their inhibition constants (IC50) for hERG channels.
Related posts:
- q-hERG: QUANTUM’s innovative approach to hERG binding calculations is finally released
- HERG binding prediction quality: q-HERG model vs. experiments
- Does hERG binding correlate with LogP?
- How good are biological experiments? HERG binding data analysis
- QUANTUM and HSA binding calculations: the role of protein flexibility
